As many of you may know, my husband/consulting partner and I were approached by Roche Diabetes’ Accu-Chek team a few years back with a challenging project request: how could we help them best “embrace” the burgeoning online diabetes patient community (what is now known lovingly as the DOC)? Our suggestion was hosting an in-person summit, to offer us cyber-advocates a rare chance to meet each other, as well as an unprecedented “peek behind the curtain”…Read more »
Charles a.k.a. “Chip” Zimliki is a biologist who works at FDA. He’s an important person for all PWDs to know about in that he has a key role in developing the technology that will one day become a functioning Artificial Pancreas. Chip came to FDA as a grad student on fellowship doing pancreatic beta cell research for diabetes, which was always “near and dear to my heart,” he says, as a long-time type 1 diabetic…Read more »
The Artificial Pancreas has the potential to become a huge leap forward in diabetes care. As anxious as all of us are to push the boundaries in diabetes technology, we can’t forget the importance of clinical trials; nothing will move forward without real patients ready and willing to strap on the gear and let researchers observe them for hours on end, most of the time in a clinical setting.
That might not seem like the…Read more »
Yesterday marks “a milestone” in the development of new technology to help automate the care and treatment of type 1 diabetes, according to JDRF!
The U.S. Food and Drug Administration unveiled its eagerly awaited Draft Guidance document for research and development of the Artificial Pancreas system, and initial reaction from JDRF — in a press conference held yesterday afternoon — was a mix of jubilation and a more measured response that they remain “guardedly optimistic”…
Jeffrey Brewer is the newest president of the JDRF — following several rapid turn-overs over the past five years since the departure of Peter Van Etten. This change in leadership coincides with a dramatic shift in JDRF’s policies on the programs and research it funds, focusing not only on the cure, but also on new technologies, like the Artificial Pancreas, and research on treating complications.
Jeffrey first announced this change in a groundbreaking interview with…